Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA Teva, 12 Feb 2009 Accessed on 21 Feb 2012 from http://phx.corporate-ir.net/preview/phoenix.zhtml?c=73925&p=irol-newsArticle&ID=1555716&highlight=laquinimod. CommentRecommendBookmarkWatch
